Labcorp Holdings Operating Cash Flow Growth & History (LH)
Labcorp Holdings's operating cash flow was $1.64B for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.64B | $54.7M | +3.45% |
| 2024 | 2024-12-31 | $1.59B | $258.1M | +19.44% |
| 2023 | 2023-12-31 | $1.33B | −$628.2M | −32.12% |
| 2022 | 2022-12-31 | $1.96B | −$1.15B | −37.10% |
| 2021 | 2021-12-31 | $3.11B | $974.3M | +45.63% |
| 2020 | 2020-12-31 | $2.14B | $690.6M | +47.80% |
| 2019 | 2019-12-31 | $1.44B | $139.3M | +10.67% |
| 2018 | 2018-12-31 | $1.31B | −$192.7M | −12.86% |
| 2017 | 2017-12-31 | $1.50B | $301.0M | +25.14% |
| 2016 | 2016-12-31 | $1.20B | $214.7M | +21.85% |
| 2015 | 2015-12-31 | $982.4M | $243.4M | +32.94% |
| 2014 | 2014-12-31 | $739.0M | −$79.7M | −9.73% |
| 2013 | 2013-12-31 | $818.7M | −$22.7M | −2.70% |
| 2012 | 2012-12-31 | $841.4M | −$14.2M | −1.66% |
| 2011 | 2011-12-31 | $855.6M | −$28.0M | −3.17% |
| 2010 | 2010-12-31 | $883.6M | $21.2M | +2.46% |
| 2009 | 2009-12-31 | $862.4M | $81.5M | +10.44% |
| 2008 | 2008-12-31 | $780.9M | $71.2M | +10.03% |
| 2007 | 2007-12-31 | $709.7M | — | — |
Labcorp Holdings quarterly operating cash flow
| Fiscal quarter | Period ended | Operating cash flow | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $445.5M | −$175.1M | −28.21% |
| Q1 2026 | 2026-03-31 | $191.5M | $173.0M | +935.14% |
| Q4 2025 | 2025-12-31 | $614.2M | −$163.0M | −20.97% |
| Q3 2025 | 2025-09-30 | $387.2M | $109.9M | +39.63% |
| Q2 2025 | 2025-06-30 | $620.6M | $59.5M | +10.60% |
| Q1 2025 | 2025-03-31 | $18.5M | $48.3M | — |
| Q4 2024 | 2024-12-31 | $777.2M | $197.6M | +34.09% |
| Q3 2024 | 2024-09-30 | $277.3M | $1.8M | +0.65% |
| Q2 2024 | 2024-06-30 | $561.1M | $209.7M | +59.68% |
| Q1 2024 | 2024-03-31 | −$29.8M | −$151.0M | — |
| Q4 2023 | 2023-12-31 | $579.6M | −$74.0M | −11.32% |
| Q3 2023 | 2023-09-30 | $275.5M | −$98.3M | −26.30% |
| Q2 2023 | 2023-06-30 | $351.4M | −$221.1M | −38.62% |
| Q1 2023 | 2023-03-31 | $121.2M | −$234.8M | −65.96% |
| Q4 2022 | 2022-12-31 | $653.6M | −$43.9M | −6.29% |
| Q3 2022 | 2022-09-30 | $373.8M | −$393.5M | −51.28% |
| Q2 2022 | 2022-06-30 | $572.5M | $85.3M | +17.51% |
| Q1 2022 | 2022-03-31 | $356.0M | −$801.6M | −69.25% |
| Q4 2021 | 2021-12-31 | $697.5M | −$77.1M | −9.95% |
| Q3 2021 | 2021-09-30 | $767.3M | −$18.9M | −2.40% |
| Q2 2021 | 2021-06-30 | $487.2M | $116.5M | +31.43% |
| Q1 2021 | 2021-03-31 | $1.16B | $953.8M | +468.01% |
| Q4 2020 | 2020-12-31 | $774.6M | $204.8M | +35.94% |
| Q3 2020 | 2020-09-30 | $786.2M | $330.6M | +72.56% |
| Q2 2020 | 2020-06-30 | $370.7M | $117.2M | +46.23% |
| Q1 2020 | 2020-03-31 | $203.8M | $38.0M | +22.92% |
| Q4 2019 | 2019-12-31 | $569.8M | $83.4M | +17.15% |
| Q3 2019 | 2019-09-30 | $455.6M | $203.7M | +80.87% |
| Q2 2019 | 2019-06-30 | $253.5M | −$133.9M | −34.56% |
| Q1 2019 | 2019-03-31 | $165.8M | −$13.9M | −7.74% |
| Q4 2018 | 2018-12-31 | $486.4M | −$78.6M | −13.91% |
| Q3 2018 | 2018-09-30 | $251.9M | −$144.8M | −36.50% |
| Q2 2018 | 2018-06-30 | $387.4M | $76.9M | +24.77% |
| Q1 2018 | 2018-03-31 | $179.7M | −$46.2M | −20.45% |
| Q4 2017 | 2017-12-31 | $565.0M | $94.9M | +20.19% |
| Q3 2017 | 2017-09-30 | $396.7M | $146.8M | +58.74% |
| Q2 2017 | 2017-06-30 | $310.5M | −$39.0M | −11.16% |
| Q1 2017 | 2017-03-31 | $225.9M | $98.3M | +77.04% |
| Q4 2016 | 2016-12-31 | $470.1M | $85.5M | +22.23% |
| Q3 2016 | 2016-09-30 | $249.9M | −$38.1M | −13.23% |
| Q2 2016 | 2016-06-30 | $349.5M | −$47.2M | −11.90% |
| Q1 2016 | 2016-03-31 | $127.6M | $214.5M | — |
| Q4 2015 | 2015-12-31 | $384.6M | $170.9M | +79.97% |
| Q3 2015 | 2015-09-30 | $288.0M | $112.4M | +64.01% |
| Q2 2015 | 2015-06-30 | $396.7M | $786.0M | — |
| Q1 2015 | 2015-03-31 | −$86.9M | −$825.9M | — |
| Q4 2014 | 2014-12-31 | $213.7M | −$35.0M | −14.07% |
| Q3 2014 | 2014-09-30 | $175.6M | −$58.6M | −25.02% |
| Q2 2014 | 2014-06-30 | −$389.3M | −$526.9M | — |
| Q1 2014 | 2014-03-31 | $739.0M | $540.8M | +272.86% |
| Q4 2013 | 2013-12-31 | $248.7M | −$5.5M | −2.16% |
| Q3 2013 | 2013-09-30 | $234.2M | $30.4M | +14.92% |
| Q2 2013 | 2013-06-30 | $137.6M | −$48.7M | −26.14% |
| Q1 2013 | 2013-03-31 | $198.2M | $1.1M | +0.56% |
| Q4 2012 | 2012-12-31 | $254.2M | −$24.4M | −8.76% |
| Q3 2012 | 2012-09-30 | $203.8M | $27.0M | +15.27% |
| Q2 2012 | 2012-06-30 | $186.3M | $1.4M | +0.76% |
| Q1 2012 | 2012-03-31 | $197.1M | −$18.2M | −8.45% |
| Q4 2011 | 2011-12-31 | $278.6M | $19.4M | +7.48% |
| Q3 2011 | 2011-09-30 | $176.8M | $600,000 | +0.34% |
| Q2 2011 | 2011-06-30 | $184.9M | −$31.3M | −14.48% |
| Q1 2011 | 2011-03-31 | $215.3M | −$16.7M | −7.20% |
| Q4 2010 | 2010-12-31 | $259.2M | $34.5M | +15.35% |
| Q3 2010 | 2010-09-30 | $176.2M | −$70.2M | −28.49% |
| Q2 2010 | 2010-06-30 | $216.2M | $33.8M | +18.53% |
| Q1 2010 | 2010-03-31 | $232.0M | $23.1M | +11.06% |
| Q4 2009 | 2009-12-31 | $224.7M | — | — |
| Q3 2009 | 2009-09-30 | $246.4M | $52.0M | +26.75% |
| Q2 2009 | 2009-06-30 | $182.4M | — | — |
| Q1 2009 | 2009-03-31 | $208.9M | — | — |
| Q3 2008 | 2008-09-30 | $194.4M | — | — |
Labcorp Holdings operating cash flow trends
Over the last five fiscal years, Labcorp Holdings's operating cash flow decreased from $2.14B to $1.64B, a change of −$494.8M. The latest reported quarter, Q2 2026, shows $445.5M.
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
SEC-reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...